RecruitingNot ApplicableNCT05437588

Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents


Sponsor

University of Alabama at Birmingham

Enrollment

240 participants

Start Date

Oct 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This study is dedicated to help identify biomarkers for depression and suicide. The purpose of the study is to better understand these links to improve medical and psychiatric care in the future. This research is also to test the effects of standard treatment of depression on improvement in depressive and suicidal behavior and on biomarkers (e.g. miRNA) for these disorders.


Eligibility

Min Age: 10 YearsMax Age: 24 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at whether specific molecules found in blood plasma — called microRNAs from nerve-derived particles — can serve as early markers to predict suicidal thoughts, suicide attempts, and treatment outcomes in teenagers with depression. The goal is to develop a blood test that could help clinicians identify at-risk young people. **You may be eligible if:** - You are physically healthy and willing to provide consent (and parental consent if under 18) - You are a teenager with a diagnosis of major depressive disorder (MDD), OR you have had suicidal thoughts or a recent suicide attempt requiring medical attention, OR you are a healthy teenager with no history of mental illness **You may NOT be eligible if:** - You have a health condition that would make participation unsafe - (Healthy controls) You have any history of a major mental illness or substance use disorder Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICGenetic testing

Attempting to identify the genetic biomarker that can identify risk for suicidal ideation and action


Locations(2)

University of Alabama at Birmingham

Birmingham, Alabama, United States

UAB Huntsville Regional Medical Campus

Huntsville, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05437588


Related Trials